Trials / Terminated
TerminatedNCT02223494
Safety of Terbogrel in Patients With Primary Pulmonary Hypertension
An Open-label, Long-term Safety Evaluation of Terbogrel in Patients With Primary Pulmonary Hypertension
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Study to assess the safety of terbogrel during open-label, long-term treatment in medically stable or improving patients with primary pulmonary hypertension who have completed the 12-week, double-blind randomized trial of terbogrel (protocol 528.19)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Terbogrel |
Timeline
- Start date
- 1998-10-01
- Primary completion
- 2000-03-01
- First posted
- 2014-08-22
- Last updated
- 2014-08-22
Source: ClinicalTrials.gov record NCT02223494. Inclusion in this directory is not an endorsement.